secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0001213900-23-006428
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma announces board-authorized stock repurchase program up to $1M
-------------------------------------------------------------------------

- Board authorized repurchase of up to $1M of common stock in open market or privately negotiated transactions.
- Company had approximately 3,138,797 shares outstanding as of November 10, 2022.
- Repurchases subject to available liquidity, cash flows, market conditions, and regulatory limits.
- Program does not obligate the company to repurchase any specific amount and may be suspended or discontinued any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/0001213900-23-006428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023006428/ea172375-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-006428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer